Home

Scott Mendel

CIK 1515051 · President & CEO · last filed 2026-07-09

Scott Mendel is a President & CEO who has filed 93 SEC Form 4 insider transactions across 5 companies since 2011. The most recent filing, for QTRX, was dated Jul 9, 2026. Across all open-market trades the lifetime net is −$5.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $191.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$191.8K

Companies

5

Total Filings

93

Lifetime Open-Market Net

-$5.50M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QTRX Director 24,056 $3.49 $84.0K $0 6 2026-07-09
QSI Director 141,843 $0.76 $107.9K $0 4 2026-05-20
Akoya Biosciences, Inc. (AKYA) Delisted Director 28,500 $1.29 $36.8K $211.9K 7 2024-10-04
GenMark Diagnostics, Inc. (GNMK) Delisted President & CEO 0 $24.04 $0 -$4.12M 65 2021-04-22
ACTIVE NETWORK INC (ACTV) Delisted Chief Financial Officer 0 $33.14 $0 -$1.60M 10 2013-11-15

Recent Filings

93 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-09 QTRX Exer (M) +8,073 $0 EDGAR
2026-07-02 QTRX Grant (A) +3,456 $15.0K EDGAR
2026-05-20 QSI Grant (A) — $0 EDGAR
2026-04-07 QTRX Grant (A) +4,310 $0 EDGAR
2026-01-06 QTRX Grant (A) +25,316 $0 EDGAR
2025-10-03 QTRX Grant (A) +2,084 $11.5K EDGAR
2025-07-10 — Other (J) −28,500 $0
2025-07-10 QTRX Grant (A) +28,653 $0 EDGAR
2025-05-21 QSI Grant (A) — $0 EDGAR
2024-10-04 Akoya Biosciences, Inc. (AKYA) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 93
Page 1 of 10
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.